Ganesh Manoharan

Showing 1-9 of 9 articles

Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study

Manoharan G, Grube E, Van Mieghem N, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh J, Fan Y, Windecker S

November 20, 2020 | 10.4244/EIJ-D-20-00279

Interventions for valvular disease

Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study

Manoharan G, Grube E, Van Meighem NM, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh J, Fan Y, Windecker S

August 4, 2020 | 10.4244/EIJ-D-20-00279

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Coronary interventions

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

Manoharan G, Belardi J, Du Z, Lee M, Qiao S, Serruys P, Windecker S, Xu B, Yeung A

January 20, 2017 | 10.4244/EIJ-D-16-00079

Interventions for valvular disease

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery

Van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12SYA6

Interventions for valvular disease

Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system

Manoharan G, Linke A, Möllmann H, Redwood S, Frerker C, Kovac J, Walther T

August 20, 2016 | 10.4244/EIJV12I6A125

First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve

Jeger R, Manoharan G, Kaiser C

March 20, 2014 | 10.4244/EIJV9I11A229

St Jude Medical Portico valve

Manoharan G, Spence M, Rodés-Cabau J, Webb J

September 30, 2012 | 10.4244/EIJV8SQA18

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

An Occlutech PLD Occluder 8×4 mm is positioned through a 7 Fr catheter

November 20, 2020

Impact of Pulmonary Ridge Coverage after Left Atrial Appendage Occlusion

November 18, 2020

Lifelong learning never stops. PCR London Valves goes virtual!

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Patient preferences and Heart Team decision

November 20, 2020

This Week's JAA's: CT-QFR or myocardial perfusion imaging in patients with coronary stenosis on CTA, Spontaneous distal embolization from plaque erosion...

November 17, 2020

Valvular disease